Hester Biosciences informs about outcome of board meeting

02 Aug 2024 Evaluate
With reference to letter dated 25 July 2024 intimating the date of the Board Meeting for consideration of the unaudited standalone and consolidated financial results for the quarter ended 30 June 2024 and pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that Board of Directors, in their Meeting held today, have approved the unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2024, as recommended by Audit Committee. They attached: 1) The approved unaudited standalone and consolidated financial results and limited review reports 2) A Press Release issued in this regard they will be publishing an extract of the results in the newspaper as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board Meeting commenced at 10:30 am (IST) and concluded at 11:05 am (IST).

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

2370.15 -12.35 (-0.52%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.